These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33271910)

  • 1. Oxidized Low-Density Lipoprotein Associates with Ventricular Stress in Young Adults and Triggers Intracellular Ca
    Rodríguez-Sánchez E; Navarro-García JA; González-Lafuente L; Aceves-Ripoll J; Vázquez-Sánchez S; Poveda J; Mercado-García E; Corbacho-Alonso N; Calvo-Bonacho E; Fernández-Velasco M; Álvarez-Llamas G; Barderas MG; Ruilope LM; Ruiz-Hurtado G
    Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33271910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of oxidized low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes.
    Liu K; Massaeli H; Pierce GN
    J Biol Chem; 1993 Feb; 268(6):4145-51. PubMed ID: 8440703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime cardiovascular risk is associated with a multimarker score of systemic oxidative status in young adults independently of traditional risk factors.
    RodrÍguez-SÁnchez E; Navarro-GarcÍa JA; Aceves-Ripoll J; GonzÁlez-Lafuente L; Corbacho-Alonso N; Martinez P; Calvo-Bonacho E; Alvarez-Llamas G; Barderas MG; Ruilope LM; Ruiz-Hurtado G
    Transl Res; 2019 Oct; 212():54-66. PubMed ID: 31295436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.
    Abhayaratna WP; Marwick TH; Becker NG; Jeffery IM; McGill DA; Smith WT
    Am Heart J; 2006 Nov; 152(5):941-8. PubMed ID: 17070165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L; Dionne A; Meloche-Dumas L; Fournier A; Dahdah N
    Pediatr Cardiol; 2020 Jun; 41(5):947-954. PubMed ID: 32172336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes.
    Navarro-García JA; Delgado C; Fernández-Velasco M; Val-Blasco A; Rodríguez-Sánchez E; Aceves-Ripoll J; Gómez-Hurtado N; Bada-Bosch T; Mérida-Herrero E; Hernández E; Praga M; Salguero R; Solís J; Arribas F; Delgado JF; Bueno H; Kuro-O M; Ruilope LM; Ruiz-Hurtado G
    Nephrol Dial Transplant; 2019 Nov; 34(11):1864-1875. PubMed ID: 30629224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular calcium mishandling leads to cardiac dysfunction and ventricular arrhythmias in a mouse model of propionic acidemia.
    Tamayo M; Fulgencio-Covián A; Navarro-García JA; Val-Blasco A; Ruiz-Hurtado G; Gil-Fernández M; Martín-Nunes L; Lopez JA; Desviat LR; Delgado C; Richard E; Fernández-Velasco M
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165586. PubMed ID: 31678161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
    Nah EH; Kim SY; Cho S; Kim S; Cho HI
    BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).
    Mitchell A; Misialek JR; Folsom AR; Duprez D; Alonso A; Jerosch-Herold M; Sanchez OA; Watson KE; Sallam T; Konety SH
    Am J Cardiol; 2015 May; 115(10):1341-5. PubMed ID: 25816778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic exposure of smooth muscle cells to minimally oxidized LDL results in depressed inositol 1,4,5-trisphosphate receptor density and Ca(2+) transients.
    Massaeli H; Austria JA; Pierce GN
    Circ Res; 1999 Sep; 85(6):515-23. PubMed ID: 10488054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.